![](/img/cover-not-exists.png)
Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer
Englinger, Bernhard, Kallus, Sebastian, Senkiv, Julia, Heilos, Daniela, Gabler, Lisa, van Schoonhoven, Sushilla, Terenzi, Alessio, Moser, Patrick, Pirker, Christine, Timelthaler, Gerald, Jäger, WalterVolume:
36
Language:
english
Journal:
Journal of Experimental & Clinical Cancer Research
DOI:
10.1186/s13046-017-0592-3
Date:
December, 2017
File:
PDF, 5.41 MB
english, 2017